Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-12

FDA Approved: TOBRAMYCIN INHALATION — Original Application (Prasco, LLC)

View source ↗

Summary

The FDA approved an Original Application for Tobramycin Inhalation by Prasco, LLC, for the treatment of chronic Pseudomonas aeruginosa infection in people with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN INHALATION (TOBRAMYCIN)

Snippet

ORIG AP for TOBRAMYCIN INHALATION (TOBRAMYCIN INHALATION)